Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
ENXTBR:ARGX
argenx
|
339.90 | 0% | 0% | 20.200,62 | 0% | 0% |
|
CPSE:GMAB
Genmab A/S
|
2041.00 | 64,8% | 124,4% | 131.830,48 | 0% | 22,71% |
|
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A. |
51.20 | 18,28% | 30,99% | 10.363,08 | 2,36% | 10,99% |
|
CPSE:ZEAL
Zealand Pharma A/S
|
600.00 | 0% | 0% | 38.517,01 | 0% | 0% |
|
LSE:HIK
Hikma Pharmaceuticals PLC
|
19.78 | 25,31% | 38,17% | 4.424,39 | 2,87% | 10,04% |
|
HLSE:ORNBV
Orion Oyj
|
37.69 | 22,61% | 65,62% | 5.117,58 | 4,3% | -0,43% |
|
CPSE:ALK B
ALK-Abelló A/S
|
152.00 | 48,16% | 94,21% | 33.908,31 | 0% | 171,44% |
|
NasdaqGS:ALKS
Alkermes
|
24.15 | 179,13% | 204,47% | 4.105,31 | 0% | 18,74% |
|
XTRA:MOR
MorphoSys
|
69.35 | 0% | 0% | 2.523,4 | 0% | 0% |
|
LSE:INDV
Indivior PLC
|
13.37 | -23,61% | -1,68% | 1.952,43 | 0% | -2,7% |
|
BME:ALM
Almirall
|
9.27 | -45,22% | 27,15% | 1.944,22 | 2% | -30,96% |
|
XTRA:EVT
Evotec
|
9.76 | -32,05% | 101,29% | 1.726,81 | 0% | 0% |
|
NasdaqGM:SUPN
Supernus Pharmaceuticals
|
29.10 | 2,87% | 17,34% | 1.720,68 | 0% | -11,07% |
|
BME:FAE
Faes Farma
|
3.66 | 14,51% | 24,13% | 1.089,37 | 4,31% | 6,96% |
|
BME:PHM
Pharma Mar
|
36.72 | 0% | 0% | 536,95 | 1,79% | -39,63% |
|
SWX:BSLN
Basilea Pharmaceutica
|
43.65 | -24,32% | -26,01% | 529,94 | 0% | -15,69% |
|
ENXTPA:DBV
DBV Technologies
|
1.27 | 0% | 0% | 115,65 | 0% | 0% |
|
SWX:MOLN
Molecular Partners
|
3.31 | 0% | 0% | 110,77 | 0% | 0% |
|
NasdaqCM:ASRT
Assertio Holdings
|
1.07 | -.100% | -52,24% | 100,36 | 0% | -35,38% |
|
NasdaqCM:DRRX
DURECT
|
0.93 | 0% | 0% | 33,21 | 0% | 0% |
